BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 11503785)

  • 1. Nabumetone: new preparation. Just another NSAID.
    Prescrire Int; 2000 Apr; 9(46):43-6. PubMed ID: 11503785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
    Roth SH
    Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib in osteoarthritis and rheumatoid arthritis: new preparation. As disappointing as rofecoxib.
    Prescrire Int; 2001 Apr; 10(52):46-9. PubMed ID: 11718158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nabumetone: a clinical appraisal.
    Helfgott SM
    Semin Arthritis Rheum; 1994 Apr; 23(5):341-6. PubMed ID: 8036523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rofecoxib: new preparation. A disappointing NSAID analgesic.
    Prescrire Int; 2000 Dec; 9(50):166-7, 169. PubMed ID: 11475491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nabumetone (Relifex)--another NSAID.
    Drug Ther Bull; 1988 May; 26(11):41-3. PubMed ID: 3289871
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
    Morgan GJ; Poland M; DeLapp RE
    Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabumetone--a new NSAID.
    Med Lett Drugs Ther; 1992 Apr; 34(868):38-40. PubMed ID: 1556995
    [No Abstract]   [Full Text] [Related]  

  • 10. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAIDs for the new decade--nabumetone?
    Huskisson EC
    Eur J Rheumatol Inflamm; 1991; 11(3):1-2. PubMed ID: 1365475
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
    Lister BJ; Poland M; DeLapp RE
    Am J Med; 1993 Aug; 95(2A):2S-9S. PubMed ID: 8356999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis.
    Fleischmann RM
    J Rheumatol Suppl; 1992 Nov; 36():32-40. PubMed ID: 1474533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decision analysis model in the evaluation of NSAIDs in a managed care setting: a case study.
    Brixner DI
    Med Interface; 1994 Nov; 7(11):145-50. PubMed ID: 10138701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerability of nabumetone in the treatment of painful symptomatology of rheumatoid arthritis and osteoarthrosis].
    Riccieri V; Spadaro A; Iagnocco A
    Clin Ter; 1991 May; 137(3):185-9. PubMed ID: 1831086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the experience with nabumetone in clinical trials outside of the United States.
    Jenner PN; Johnson ES
    Am J Med; 1987 Oct; 83(4B):110-4. PubMed ID: 3318421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
    Eversmeyer W; Poland M; DeLapp RE; Jensen CP
    Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of nabumetone in United States clinical trials.
    Jackson RE; Mitchell FN; Brindley DA
    Am J Med; 1987 Oct; 83(4B):115-20. PubMed ID: 3318422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rofecoxib in rheumatoid arthritis: new indication. No better that other NSAIDS.
    Prescrire Int; 2003 Jun; 12(65):89-90. PubMed ID: 12825570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis.
    Simon LS; Zhao SZ; Arguelles LM; Lefkowith JB; Dedhiya SD; Fort JG; Johnson KE
    Clin Ther; 1998; 20(6):1218-35; discussion 1192-3. PubMed ID: 9916614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.